Gyre Therapeutics, Inc.

GYRE Nasdaq SEC CIK 1124105
Follow Gyre Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $32.9M +0.7% vs same quarter last year
Net income −$2.5M −228.6% vs same quarter last year
EPS, diluted −$0.04 −500% vs same quarter last year
Operating cash flow −$4M −54.2% vs same quarter last year
Revenue by quarter
$27.9M
$22.1M
$29.7M
$32.7M
$23.6M
$22.5M
$29.1M
$32.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$100M$0$100M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$116.6M$9.9M
FY24$105.8M$17.9M
FY23$113.5M−$85.5M
FY22$102.3M$4.3M
FY21$7.3M−$87.9M
FY20$20.9M−$56.2M
FY19-−$55.2M
FY18$6K−$30.1M
FY17$1M−$21.6M
FY16-−$16.9M
FY15-−$14.8M
FY14$275K−$6.6M
FY13$3.6M−$10M
FY12$57.9M−$7M
FY11$97.6M−$8.5M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−600000%−400000%−200000%0%200000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2595.4%9.9%8.5%
FY2496.3%15.3%16.9%
FY2395.9%−59.3%−75.3%
FY2295.3%9%4.2%
FY21-−1197.8%−1198.3%
FY20-−273.9%−268.5%
FY19---
FY18-−563700%−500916.7%
FY17-−2143.6%−2118%
FY16---
FY15---
FY14-−2730.5%−2404.7%
FY13-−278.9%−274.6%
FY12-−14.1%−12.1%
FY11-−10%−8.7%
Free cash flowOperating cash flow minus capital expenditure
−$100M−$50M$0$50MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25−$180K
FY24−$6M
FY23$17.4M
FY22$5.7M
FY21−$84.6M
FY20-
FY19−$43.7M
FY18−$28.9M
FY17−$20M
FY16−$18.9M
FY15−$19.4M
FY14−$6.4M
FY13−$40.7M
FY12−$64.6M
FY11−$85.1M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Gyre Therapeutics
  • Healthcare median
−600000%−400000%−200000%0%200000%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGyre TherapeuticsHealthcare median
FY258.5%−30.6%
FY2416.9%−47%
FY23−75.3%−58%
FY224.2%−80.4%
FY21−1198.3%−71.8%
FY20−268.5%−62.2%
FY19-−46.2%
FY18−500916.7%−49.6%
FY17−2118%−45.9%
FY16-−36%
FY15-−37.8%
FY14−2404.7%−35.5%
FY13−274.6%−37.1%
FY12−12.1%−29.1%
FY11−8.7%−27.9%